Innovative cancer drug targets: genomics, transcriptomics and clinomics

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.6, 2001-06, pp. : 911-915

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discovering New Schistosome Drug Targets: The Role of Transcriptomics

Current Drug Targets, Vol. 9, Iss. 11, 2008-11 ,pp. : 922-930

Bentham Science Publishers

Access to resources Recommend Favorite

Deductive Genomics: A Functional Approach to Identify Innovative Drug Targets in the Post-Genome Era

Pharmaceutical Innovation, Vol. 12, Iss. 4, 2003-06 ,pp. : 31-38

Adis International

Access to resources Recommend Favorite

Deductive Genomics: A Functional Approach to Identify Innovative Drug Targets in the Post-Genome Era

By Stumm G. Russ A. Nehls M.

American Journal of PharmacoGenomics, Vol. 2, Iss. 4, 2002-01 ,pp. : 263-271

Adis International

Access to resources Recommend Favorite

Genomics and Cancer Drug Resistance

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 5, 2012-04 ,pp. : 651-673

Bentham Science Publishers

Access to resources Recommend Favorite

Human genomics and obesity: finding appropriate drug targets

By Ravussin E. Bouchard C.

European Journal of Pharmacology, Vol. 410, Iss. 2, 2000-12 ,pp. : 131-145

Elsevier

Access to resources Recommend Favorite